Fernando Rodrigues Sells 4,209 Shares of Teladoc Health (NYSE:TDOC) Stock

Teladoc Health, Inc. (NYSE:TDOC) insider Fernando Rodrigues sold 4,209 shares of the firm’s stock in a transaction that occurred on Wednesday, December 3rd. The shares were sold at an average price of $7.48, for a total value of $31,483.32. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Teladoc Health Stock Up 3.2%

NYSE:TDOC opened at $7.77 on Friday. Teladoc Health, Inc. has a 1-year low of $6.35 and a 1-year high of $15.21. The company has a 50-day moving average of $8.02 and a 200 day moving average of $7.76. The firm has a market cap of $1.38 billion, a PE ratio of -6.07 and a beta of 2.04. The company has a debt-to-equity ratio of 0.71, a current ratio of 2.70 and a quick ratio of 2.60.

Teladoc Health (NYSE:TDOC) last announced its quarterly earnings data on Wednesday, October 29th. The health services provider reported ($0.21) EPS for the quarter, beating the consensus estimate of ($0.26) by $0.05. The firm had revenue of $626.44 million during the quarter, compared to analyst estimates of $625.66 million. Teladoc Health had a negative net margin of 8.84% and a negative return on equity of 10.59%. Teladoc Health’s revenue was down 2.2% on a year-over-year basis. During the same period last year, the firm posted ($0.19) EPS. Teladoc Health has set its Q4 2025 guidance at -0.250–0.100 EPS. As a group, research analysts anticipate that Teladoc Health, Inc. will post -1.16 EPS for the current fiscal year.

Hedge Funds Weigh In On Teladoc Health

Hedge funds have recently made changes to their positions in the business. Allianz Asset Management GmbH lifted its stake in shares of Teladoc Health by 105.0% during the 1st quarter. Allianz Asset Management GmbH now owns 20,700 shares of the health services provider’s stock worth $165,000 after buying an additional 10,600 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in Teladoc Health by 4.4% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 65,623 shares of the health services provider’s stock valued at $522,000 after acquiring an additional 2,748 shares during the last quarter. Mackenzie Financial Corp lifted its stake in Teladoc Health by 652.8% in the first quarter. Mackenzie Financial Corp now owns 81,208 shares of the health services provider’s stock valued at $646,000 after buying an additional 70,420 shares during the period. Federated Hermes Inc. increased its holdings in shares of Teladoc Health by 18.1% during the first quarter. Federated Hermes Inc. now owns 398,791 shares of the health services provider’s stock valued at $3,174,000 after acquiring an additional 61,194 shares in the last quarter. Finally, XTX Topco Ltd purchased a new stake in shares of Teladoc Health in the first quarter worth approximately $557,000. 76.82% of the stock is owned by institutional investors.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on TDOC shares. BMO Capital Markets initiated coverage on shares of Teladoc Health in a research report on Thursday, November 13th. They set a “market perform” rating and a $8.00 price objective for the company. Evercore ISI decreased their price target on Teladoc Health from $9.00 to $8.00 and set an “in-line” rating on the stock in a research note on Thursday, October 30th. Weiss Ratings reiterated a “sell (e+)” rating on shares of Teladoc Health in a report on Monday. Zacks Research lowered Teladoc Health from a “strong-buy” rating to a “hold” rating in a research report on Monday, November 10th. Finally, Bank of America cut their target price on Teladoc Health from $9.00 to $8.00 and set a “neutral” rating on the stock in a research note on Tuesday, November 25th. Five research analysts have rated the stock with a Buy rating, eleven have given a Hold rating and one has given a Sell rating to the company. According to MarketBeat, the company currently has a consensus rating of “Hold” and a consensus target price of $9.68.

About Teladoc Health

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.